Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy.
- Resource Type
- Article
- Source
- Nature; 6/6/2019, Vol. 570 Issue 7759, p112-116, 5p, 14 Graphs
- Subject
- Language
- ISSN
- 00280836